封锁
结直肠癌
医学
肿瘤科
临床试验
内科学
癌症
受体
作者
Zehua Wu,Yuanzhe Zhang,Yi Cheng,Jianxia Li,Fangqian Li,Chao Wang,Lishuo Shi,Ge Qin,Weixiang Zhan,Yue Cai,Xiaoyu Xie,Jiayu Ling,Huabin Hu,Jianwei Zhang,Yanhong Deng
出处
期刊:Med
[Elsevier BV]
日期:2024-05-24
卷期号:5 (8): 998-1015.e6
被引量:4
标识
DOI:10.1016/j.medj.2024.05.002
摘要
Approximately 20% of patients with DNA mismatch repair deficiency (dMMR) metastatic colorectal cancer do not respond to anti-programmed death-1 (PD-1) ligand therapy, and baseline biomarkers of response are lacking.
科研通智能强力驱动
Strongly Powered by AbleSci AI